Relapsed/Refractory - Globe Thesis

Keyword [Relapsed/Refractory] Result: 41 - 60 \| Page: 3 of 4
41.	A Study Of The Effects Of Haploidentical Donor And Matched Sibling Donor Transplantation In Adult Acute Myeloid Leukemia
42.	Clinical Study Of RMT Regimen In The Treatment Of PCNSL And Clinical And In Vitro Study Of MTOR Inhibitor RAD001 Combined With Gemcitabine In PTCL
43.	Hematologic Toxicity And Kinetics Of Immune Function And Relevant Factors Analysis After Chimeric Antigen Receptor T Cells Therapy In Relapsed/Refractory Acute B Lymphoblastic Leukemia
44.	Efficacy,safety And Prognosis Analysis Of Chidamide Combined With Etoposide Capsules In The Treatment Of R/RNK/T Cell Lymphoma
45.	Clinical Study Of Low-dose Decitabine Combined With HAG In The Treatment Of Elderly And Relapsed /Refractory Acute Myeloid Leukemia
46.	Combination Of Homoharringtonine And Venetoclax Synergistic Improves Treatment Response And Underlying Molecular Mechanism In Relapsed/Refractory AML
47.	The Efficacy And Side Effects Of PI3K Inhibitor In The Treatment Of Relapsed/refractory Chronic Lymphocytic Leukemia:a Meta Analysis
48.	Efficacy And Safety Of Elotuzumab In The Treatment Of Relapsed/refractory Multiple Myeloma:Meta Analysis
49.	The Prognostic Factors Analysis And Treatment Selection Of Relapsed/refractory B-cell Acute Lymphocytic Leukemia
50.	A Clinical Study Of Fourth-generation CD19-CAR T-cells In The Threapy Of Relapsed/Refractory Adult Acute B Lymphocytic Leukemia
51.	A Meta-analysis Of The Efficacy And Safety Of PD-1 Inhibitors In Treatment Of Relapsed/refractory Hodgkin Lymphoma
52.	Safety And Efficacy Of Anti-PD-1/PD-l1 Antibodies In Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma:a Meta-Analysis
53.	A Meta-analysis Of The Efficacy And Safety Of Chimeric Antigen Receptor-T Cells In The Treatment Of Relapsed/Refractory B-cell Lymphoma
54.	Clinical And Experimental Study Of Chimeric Antigen Receptor Modified T Cells For Relapsed/Refractory Acute Lymphoblastic Leukemia In Children And Adolescents
55.	Study On The Mechanism Of Human-derived CD19 CAR-T Cell Therapy In Rescuing Relapsed/Refractory Diffuse Large B-cell Lymphoma Unresponsive To Mouse-derived CD19 CAR-T Cell Therapy
56.	Preclinical And Single-arm,prospective Clinical Trials Of Fourth-generation CAR-T Cells In Relapsed/refractory Multiple Myeloma And Solid Tumors
57.	Study On TCM Syndromes Of CAR-T Therapy For Relapsed/refractory Diffuse Large B-cell Lymphoma And Analysis Of Related Factors Affecting Efficac
58.	Efficacy And Safety Of Targeted BCMA CAR-T Therapy For Relapsed/refractory Multiple Myeloma
59.	The Efficacy And Safety Of Selinexor In The Treatment Of Relapsed/refractory Multiple Myeloma:meta Analysis
60.	Treatment Effect Of Chidamide In The Conditioning Regimen Of Allogeneic Hematopoietic Stem Cell Transplantation In Relapsed/Refractory Acute Leukemia
<<First <Prev Next> Last>> Jump to